Drug Guide
 

Alemtuzumab

Bookmark
  •  
    IV
    Alemtuzumab
    MabCampath (CLL), LemTrada (MS) 
    • Mechanism of Action
    • A humanized monoclonal antibody that binds to CD-52 receptors found on mature lymphocytes, initiating complement-mediated and antibody-dependent cell-mediated cytotoxicity.

Clinical Use

    • Indications
    • B cell chronic lymphocytic leukaemia (CLL)
    • Relapsing multiple sclerosis (MS)
    • Adverse Effects
    • Bone marrow suppression – leucopaenia, anaemia, thrombocytopaenia
    • Nausea / vomiting / diarrhoea / anorexia
    • Headache
    • Confusion
    • Hypotension
    • Dyspnoea
    • Arthralgia / myalgia
    • Rash
    • Fatigue
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Explore
   
 
Feedback